TY - JOUR
T1 - Family history of colorectal cancer in first-degree relatives and metachronous colorectal adenoma
AU - Jacobs, Elizabeth T.
AU - Gupta, Samir
AU - Baron, John A.
AU - Cross, Amanda J.
AU - Lieberman, David A.
AU - Murphy, Gwen
AU - Martínez, María Elena
N1 - Funding Information:
Guarantor of the article: Elizabeth T. Jacobs, PhD. Specific authors’ contributions: Jacobs, Gupta, and Martinez were responsible for planning and/or conducting the study, collecting and interpreting data, and drafting the manuscript. Jacobs, Gupta, and Martinez have all approved the final version of the manuscript. Baron, Cross, Lieberman, and Murphy all aided in collecting and interpreting data and drafting the manuscript. Baron, Cross, Lieberman, and Murphy have all approved the final version of the manuscript. Financial support: This work was supported by Public Health Service grants P30CA023074, CA41108, CA23074, CA95060, CA37287, CA104869, CA23108, CA59005, and CA26852 from the National Cancer Institute. Funding for the Veteran’s Affairs Study was supported by the Cooperative Studies Program, Department of Veterans Affairs. Support was also provided in part by Merit Review Award number 1 I01 HX001574-01A1 (Gupta, PI) from the United States Department of Veterans Affairs Health Services Research & Development Service of the VA Office of Research and Development. The views expressed in this article are those of the author(s) and do not necessarily represent the views of the Department of Veterans Affairs. Additional support was provide by Instituto de Salud Carlos III and Fondos FEDER (PI11/2630, INT-13-078, INT-14-196, UGP-13-221, PI14/01386), and the Intramural Research Program of the National Cancer Institute (Murphy). Funding sponsors had no role in the study design, collection, analysis, interpretation of data, or writing the report. Potential competing interests: None.
Publisher Copyright:
© 2018 American College of Gastroenterology.
PY - 2018/6/1
Y1 - 2018/6/1
N2 - Objectives: Little is known about the relationship between having a first-degree relative (FDR) with colorectal cancer (CRC) and risk for metachronous colorectal adenoma (CRA) following polypectomy. Methods: We pooled data from seven prospective studies of 7697 patients with previously resected CRAs to quantify the relationship between having a FDR with CRC and risk for metachronous adenoma. Results: Compared with having no family history of CRC, a positive family history in any FDR was significantly associated with increased odds of developing any metachronous CRA (OR = 1.14; 95% CI = 1.01-1.29). Higher odds of CRA were observed among individuals with an affected mother (OR = 1.27; 95% CI = 1.05-1.53) or sibling (OR = 1.34; 95% CI = 1.11-1.62) as compared with those without, whereas no association was shown for individuals with an affected father. Odds of having a metachronous CRA increased with number of affected FDRs, with ORs (95% CIs) of 1.07 (0.93-1.23) for one relative and 1.39 (1.02-1.91) for two or more. Younger age of diagnosis of a sibling was associated with higher odds of metachronous CRA, with ORs (95% CIs) of 1.66 (1.08-2.56) for diagnosis at <54 years; 1.34 (0.89-2.03) for 55-64 years; and 1.10 (0.70-1.72) for >65 years (p-trend = 0.008). Although limited by sample size, results for advanced metachronous CRA were similar to those for any metachronous CRA. Conclusions: A family history of CRC is related to a modestly increased odds of metachronous CRA. Future research should explore whether having a FDR with CRC, particularly at a young age, should have a role in risk stratification for surveillance colonoscopy.
AB - Objectives: Little is known about the relationship between having a first-degree relative (FDR) with colorectal cancer (CRC) and risk for metachronous colorectal adenoma (CRA) following polypectomy. Methods: We pooled data from seven prospective studies of 7697 patients with previously resected CRAs to quantify the relationship between having a FDR with CRC and risk for metachronous adenoma. Results: Compared with having no family history of CRC, a positive family history in any FDR was significantly associated with increased odds of developing any metachronous CRA (OR = 1.14; 95% CI = 1.01-1.29). Higher odds of CRA were observed among individuals with an affected mother (OR = 1.27; 95% CI = 1.05-1.53) or sibling (OR = 1.34; 95% CI = 1.11-1.62) as compared with those without, whereas no association was shown for individuals with an affected father. Odds of having a metachronous CRA increased with number of affected FDRs, with ORs (95% CIs) of 1.07 (0.93-1.23) for one relative and 1.39 (1.02-1.91) for two or more. Younger age of diagnosis of a sibling was associated with higher odds of metachronous CRA, with ORs (95% CIs) of 1.66 (1.08-2.56) for diagnosis at <54 years; 1.34 (0.89-2.03) for 55-64 years; and 1.10 (0.70-1.72) for >65 years (p-trend = 0.008). Although limited by sample size, results for advanced metachronous CRA were similar to those for any metachronous CRA. Conclusions: A family history of CRC is related to a modestly increased odds of metachronous CRA. Future research should explore whether having a FDR with CRC, particularly at a young age, should have a role in risk stratification for surveillance colonoscopy.
UR - http://www.scopus.com/inward/record.url?scp=85042233798&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85042233798&partnerID=8YFLogxK
U2 - 10.1038/s41395-018-0007-x
DO - 10.1038/s41395-018-0007-x
M3 - Article
C2 - 29463834
AN - SCOPUS:85042233798
SN - 0002-9270
VL - 113
SP - 899
EP - 905
JO - American Journal of Gastroenterology
JF - American Journal of Gastroenterology
IS - 6
ER -